Last updated: June 20, 2026
Accuracy in ambulatory cardiac monitoring depends on both signal fidelity and diagnostic yield. Diagnostic yield reflects the percentage of monitored patients in whom clinicians identify a clinically actionable finding. These two dimensions do not always favor the same device, so clinics must balance both.
Real-world data from more than 1.1 million Zio users presented at the ACC 2025 Scientific Sessions showed that long-term continuous monitoring can outperform traditional Holter monitoring and event recorders for arrhythmia diagnosis. This improvement translates into fewer emergency department visits and hospitalizations.
AI-powered alert triage has become a meaningful differentiator in 2025–2026. Integration of advanced software and automated data interpretation in monitoring systems reduces clinician review time, supports faster arrhythmia identification, and improves data visualization clarity through digital dashboards. AI accuracy at the device level only delivers value when the receiving workflow can act on the output quickly. Clinics running five or more OEM portals simultaneously report that alert fatigue, not device sensitivity, now drives most missed critical events.
Understanding which device types contribute to portal fragmentation starts with mapping the full portfolio most practices deploy. Cardiology and electrophysiology practices use a tiered set of monitors matched to clinical indication and monitoring duration:
In integrated health systems, a single patient may carry a CIED from one manufacturer while also enrolled in an RPM program using a wearable patch from another. This pattern creates the multi-OEM data fragmentation that drives operational inefficiency and alert overload.
Continuous monitoring outperforms event-based monitoring for conditions with asymptomatic or infrequent episodes. The EMBRACE randomized trial showed that extended external monitoring detected more atrial fibrillation in cryptogenic stroke patients than 24-hour Holter monitoring. Higher detection rates support more frequent oral anticoagulation prescription when appropriate.
For heart-failure management, continuous monitoring extends beyond rhythm surveillance to hemodynamic parameters. Mobile cardiac telemetry has been associated with reduced care costs and lower readmission rates compared with implantables. Cloud-based dashboards that synthesize multivariate data, including blood pressure, SpO2, and activity, now inform medication titration and triage decisions.
The 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke recommends cardiac monitoring in patients with embolic stroke of undetermined source when clinicians would consider anticoagulation if atrial fibrillation is detected. This guidance directly ties monitoring duration to treatment decision thresholds and strengthens the clinical case for extended continuous monitoring over short-duration Holter studies.
Diagnostic yield from extended monitoring depends heavily on whether patients wear the device for the full prescribed duration. Compliance data from patch-based monitors offers a useful benchmark:
Device form factor, waterproofing, and the absence of lead wires drive most patient-reported preferences. Dropout risk increases with bulkier devices, skin sensitivity, and weak patient education at enrollment. Practices that automate patient onboarding communications, including wear instructions and compliance reminders, report meaningfully lower dropout rates than those that rely on manual outreach alone.
Alert fatigue and missed critical events represent the most damaging operational consequences of multi-OEM fragmentation. When device technicians must log into separate portals for Medtronic, Boston Scientific, Abbott, and Biotronik transmissions, non-urgent alerts accumulate while genuinely critical events, such as new-onset ventricular tachycardia, lead fracture, or significant weight gain in a heart-failure patient, risk delayed response.
Interoperability standards such as IEEE 11073 accelerate integration with electronic health records and support more seamless clinician workflows. The competitive hierarchy now favors platforms that pair predictive analytics with end-to-end care pathways rather than standalone hardware.
Practical integration requirements for multi-OEM environments fall into three layers. The data ingestion layer must support API and HL7 feeds from all major OEM transmission networks, with PDF parsing via computer vision as a fallback for legacy or non-API-enabled devices. The clinical workflow layer requires bi-directional EHR integration with Epic, Cerner, Athenahealth, and eClinicalWorks to eliminate manual transcription, plus role-based mobile access so on-call clinicians can review and act on transmissions outside the office. The revenue layer depends on automated CPT code documentation for 93298, 99454, and 99457 to prevent billing leakage, which becomes possible only after unifying the data ingestion and workflow layers.
Schedule a demo to see Rhythm360's multi-OEM integration architecture in a live environment.
The table below compares four widely used ambulatory cardiac monitor categories across the four operational dimensions that most directly affect revenue capture and clinical response times in multi-device practices. Use this comparison to identify which monitor types require the most workflow intervention to achieve billing compliance and timely alert response. All figures are drawn from cited sources. When a manufacturer has not published a specific metric, the cell is marked N/A.
| Monitor Type | Integration Readiness (EHR/API) | Data Transmission Reliability | Mobile Clinician Access | CPT Billing Capture Capability |
|---|---|---|---|---|
| Patch-based LTCM (e.g., Zio) | HL7/API available; standards-based integration available | High prescribed wear-time compliance (see patient compliance section) | Physician portal available, mobile app availability varies by institution | Supports standard long-term continuous monitoring billing codes per Anthem CG-MED-40 (2026) |
| Standard Holter (24–48 hr) | Varies by vendor, and many legacy systems still require manual upload | Cloud-based access supports remote physician review with efficiency gains in reporting | Limited mobile access, typically workstation-dependent | Supports standard Holter monitoring billing codes per payer coverage policies |
| Mobile Cardiac Telemetry (MCT) | Real-time transmission, with integration quality varying by monitoring center | Associated with reduced 18-month care costs and lower readmissions compared with implantables | Monitoring center intermediary, and direct mobile access varies | Anthem CG-MED-40 excludes Mobile Cardiac Telemetry devices equipped for real-time physician notification and does not reference CPT codes 93268–93272. |
| CIED Remote Monitoring (multi-OEM) | OEM-specific portals, with standards-based EHR integration available through vendor-neutral platforms | Varies by OEM, and redundant feed architecture is required for more than 99.9% transmissibility | OEM apps available, while unified mobile access requires a vendor-neutral platform | Supports CPT codes 93297 and 93298, but fragmented portals increase missed-billing risk |
Evaluating the best ambulatory cardiac monitor for a cardiology or EP practice requires a consistent set of criteria. These include diagnostic yield for the target indication, patient compliance over the prescribed wear duration, data transmission reliability, EHR integration depth, mobile clinician access, and CPT billing capture capability. No single device category leads on every dimension, so most practices deploy a portfolio of monitors rather than a single device type.
The more consequential operational decision concerns how the portfolio is managed after deployment. Practices running three or more OEM device lines without a unified data layer face compounding risks. These risks include alert fatigue from siloed notification queues, revenue leakage from incomplete CPT documentation, and clinical liability from delayed response to critical events.
Rhythm360 by RhythmScience is a vendor-neutral, HIPAA-compliant cloud platform built to eliminate these risks. It ingests and normalizes data from all major CIED manufacturers, including Medtronic, Boston Scientific, Abbott, Biotronik, and others, alongside wearable RPM devices. The platform uses API, HL7, XML, and AI-powered PDF parsing to achieve greater than 99.9% data transmissibility. A redundant feed architecture maintains data continuity even when an OEM server becomes unavailable.
The platform's AI-driven alert triage filters non-actionable notifications and surfaces clinically significant events such as new-onset AFib, ventricular tachycardia, lead malfunction, and ERI/RRT indicators. This approach reduces critical response times by up to 80%. Automated CPT documentation for codes including 93298, 99454, and 99457 closes the billing gap that fragmented portals leave open, and practices report up to 300% revenue improvement after implementation. An optional 24/7 CCT oversight layer, supervised by physicians, provides continuous monitoring coverage without expanding in-house staffing.
Bi-directional EHR integration with Epic, Cerner, Athenahealth, and eClinicalWorks removes manual transcription from daily workflows. A HIPAA-compliant mobile application allows clinicians to review transmissions, sign reports, and coordinate care from any location. Implementation, including EHR integration, typically completes within days to a few weeks.
A Holter monitor records cardiac electrical activity continuously for 24 to 48 hours and is used for initial arrhythmia screening in patients with frequent symptoms. A cardiac event monitor records for up to 30 days and captures rhythm data either continuously or only when triggered by a symptomatic episode or an automated detection algorithm. Event monitors produce higher diagnostic yield for intermittent arrhythmias because the extended monitoring window increases the probability of capturing an episode. The two device types are billed under separate CPT code families, and payer guidelines such as Anthem CG-MED-40 specify distinct coverage criteria for each duration category.
CPT 93298 covers remote monitoring of a previously implanted cardiac device with a physician or qualified healthcare professional analysis and report, typically applied to pacemakers, ICDs, and CRT devices. CPT 99454 covers the supply of a remote physiological monitoring device and daily recording or programmed alert transmission for a minimum of 16 days in a 30-day period, applicable to wearable RPM devices used in heart-failure and hypertension management. CPT 99457 covers the first 20 minutes of interactive communication with a patient per calendar month in connection with an RPM service. Accurate capture of these codes requires automated documentation of transmission dates, alert responses, and clinician interaction times. Fragmented OEM portals rarely generate this documentation in a billing-ready format without manual intervention.
Alert fatigue occurs when the volume of device notifications exceeds a clinical team's capacity to review and act on each one in a timely manner. In multi-OEM environments, each manufacturer's portal generates its own alert queue with its own severity classifications, which creates redundant and inconsistent notification streams. Clinicians habituated to high alert volumes begin to deprioritize or delay review, which increases the risk that a genuinely critical event such as ventricular fibrillation, complete heart block, or a lead fracture is missed.
AI-powered triage systems address this problem by filtering non-actionable transmissions, consolidating alerts from all device types into a single ranked queue, and escalating only those events that meet predefined clinical thresholds. Rhythm360's alert triage architecture reduces critical response times by up to 80% by applying this filtering logic across all connected OEM data streams simultaneously.
A single vendor-neutral platform can manage both implantable device monitoring and wearable RPM programs when it is designed for cardiology workflows. These platforms ingest data from CIED remote monitoring networks and wearable RPM devices, including weight scales, blood pressure cuffs, pulse oximeters, and patch-based ECG monitors, into a unified dashboard. This unified view matters clinically because heart-failure patients often carry an ICD or CRT device while also enrolled in an RPM program for daily weight and blood pressure tracking.
Managing these data streams in separate systems creates gaps in the longitudinal patient record and increases the risk of missing a decompensation signal. Rhythm360 supports both Rhythm-CIED and HF/HTN RPM service lines within a single platform, so device technicians and clinicians can view a complete patient picture without switching applications.
Implementation timelines vary based on the number of OEM integrations required, the complexity of the EHR environment, and the size of the existing device population. For most cardiology practices and EP clinics, a full implementation, including EHR integration with systems such as Epic, Cerner, or Athenahealth, completes within a few days to a few weeks.
The primary implementation tasks include credentialing with each OEM's remote monitoring network, configuring HL7 or API data feeds, mapping alert thresholds to the practice's clinical protocols, and training staff on the unified dashboard. A streamlined onboarding process minimizes disruption to existing workflows and allows practices to begin capturing data and billing documentation from the platform shortly after go-live.
